Lundbeck’s decade-long damages bid against Sandoz stayed despite High Court win

Christian Dimitriadis 2023-07-04 11:39 pm By Cindy Cameronne | Sydney

Please login to bookmark

Novartis unit Sandoz has won its bid to stay a case by rival Lundbeck, including orders for damages previously calculated at $26.3 million and counting, despite having succeeded at the High Court in a dispute over its patent for blockbuster antidepressant Lexapro.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au